Security Directory

Biogen Taiwan operates as a regional branch of the global biotechnology leader Biogen, specializing in innovative drug development for complex neurological and rare diseases. The website reflects a mature digital presence with a focus on corporate branding, patient and healthcare professional engagement, and compliance with privacy regulations. The technical infrastructure leverages Adobe Experience Manager CMS, modern JavaScript libraries, and integrates Google Analytics and Cookiebot for analytics and consent management. Security posture is strong with HTTPS, secure cookies, and consent mechanisms, though explicit security policies and incident response details are not published. Overall, the site is professional, trustworthy, and well-optimized for its target audience in Taiwan.

Biogen NZ Biopharma Limited operates a professional and well-structured website focused on biotechnology and healthcare, specifically targeting New Zealand residents and healthcare professionals. The company emphasizes innovation in neurology, neuropsychiatry, specialized immunology, and rare diseases. The website reflects a mature digital presence with clear navigation, professional design, and integration with global Biogen branding and social media channels. Technically, the site leverages Adobe Experience Manager CMS, modern JavaScript libraries, and cookie consent management, indicating a solid digital infrastructure. Security posture is good with HTTPS enforced and cookie consent mechanisms, though explicit security policies and incident response contacts are absent. WHOIS data is unavailable, which raises some concerns about domain transparency but does not detract from the overall legitimacy given the strong brand consistency and external references. Overall, the website scores well in content quality, technical implementation, security, privacy compliance, and business credibility, making it a trustworthy and professional corporate site.

Biogen Australia Pty Ltd operates as a leading biotechnology company focused on pioneering scientific innovations for complex diseases, particularly in neurology, neuropsychiatry, specialized immunology, and rare diseases. The company positions itself as a global leader with a strong commitment to serving humanity through science, advancing health, sustainability, and equity. The website targets healthcare professionals, patients, and potential employees, offering detailed information about disease areas, medicines, corporate responsibility, and career opportunities. Technically, the website is built on Adobe Experience Manager CMS, utilizing modern JavaScript libraries such as jQuery and Adobe Helix RUM for performance monitoring. It implements cookie consent via Cookiebot and uses Google Tag Manager for analytics. The site is mobile-optimized with good SEO practices and a professional design, though accessibility features are basic. From a security perspective, the site enforces HTTPS and includes cookie consent mechanisms, but lacks visible security headers and published security policies or incident response contacts. No vulnerabilities or exposed sensitive data were detected in the HTML content. WHOIS data is privacy protected, which is typical for large enterprises, though it limits transparency. Overall, the site demonstrates a solid security posture but could improve transparency and security best practices. The overall risk assessment is low, with recommendations to publish security policies, enhance security headers, and provide incident response contacts to improve trust and compliance. The site is professional, trustworthy, and well-maintained, supporting Biogen's market position as a leading biotechnology company.

Biogen Uruguay is a regional website for Biogen, a global leader in biotechnology founded in 1978. The company specializes in innovative therapies for complex neurological and rare diseases, including multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease. The website targets a general audience including healthcare professionals and patients in Uruguay, providing information about the company's mission, therapeutic areas, and corporate responsibility. The business model is focused on pharmaceutical innovation and patient care, supported by a strong global presence and regional localization. Technically, the website is built on Adobe Experience Manager CMS, leveraging modern JavaScript libraries such as jQuery and Adobe Helix RUM for performance monitoring. It uses Cookiebot for GDPR-compliant cookie consent management and integrates Google Analytics and Google Tag Manager for analytics and marketing. The site is hosted on AWS infrastructure, inferred from load balancer cookies. The site demonstrates good mobile optimization and SEO practices, though accessibility features are basic. From a security perspective, the site enforces HTTPS and uses HttpOnly cookies to protect session data. However, no explicit security headers were detected in the HTML content, and there is no visible security policy or incident response contact information. The cookie consent mechanism is robust and GDPR compliant. No vulnerabilities or exposed sensitive data were found. The WHOIS data is consistent with the business claims, showing a legitimate and established domain. Overall, the website presents a professional and trustworthy digital presence for Biogen in Uruguay, with strong privacy compliance and good technical implementation. Recommendations include enhancing security headers, publishing a security policy, and adding vulnerability disclosure information to further improve security posture and trust.

Biogen México is a leading biotechnology company specializing in innovative therapies for complex and devastating diseases, including neurological, neuropsychiatric, specialized immunology, and rare diseases. The company operates as a subsidiary of the global Biogen Inc., founded in 1978, and maintains a strong market position as a pioneer in biotechnology. The website reflects a professional corporate presence targeting a general audience, including healthcare professionals and patients in Mexico. The business model focuses on research, development, and commercialization of transformative medicines.

BIIB Colombia is a regional subsidiary of Biogen Inc., a global leader in biotechnology founded in 1978. The company focuses on developing innovative therapies for complex and devastating diseases, including neurological, neuropsychiatric, specialized immunology, and rare diseases. The website presents a professional and consistent corporate image, targeting Spanish-speaking audiences in Colombia with comprehensive information about the company, its therapeutic areas, and career opportunities. The digital infrastructure leverages Adobe Experience Manager CMS, modern JavaScript libraries, and integrates Google Analytics and Cookiebot for privacy compliance. Security posture is solid with HTTPS enforcement and cookie consent mechanisms, though some security headers and explicit incident response policies are absent. WHOIS data is redacted, a common practice for corporate domains, and does not raise immediate concerns. Overall, the site demonstrates good technical maturity, privacy compliance, and business credibility.

Biogen Canada Inc operates as a leading biotechnology company focused on pioneering scientific innovations for complex diseases, including neurology, neuropsychiatry, immunology, and rare diseases. The company maintains a strong market position as a global leader in biotechnology, with a clear focus on advancing therapies and digital health solutions. The website targets Canadian residents, healthcare professionals, patients, and potential employees, reflecting a comprehensive corporate presence with detailed information about disease areas, science and innovation, responsibility, and careers. Technically, the website is built on Adobe Experience Manager CMS, utilizing modern JavaScript libraries such as jQuery and Adobe Helix RUM for performance monitoring. Cookiebot manages cookie consent, and Google Tag Manager is used for analytics and marketing tags. The site is mobile-optimized with good SEO and accessibility features, although some accessibility aspects could be improved. Performance is moderate, with a professional and consistent design. From a security perspective, the site enforces HTTPS and implements cookie consent mechanisms, but lacks explicit security headers and published security or incident response policies. No vulnerabilities or exposed sensitive data were detected in the HTML content. The absence of WHOIS data suggests privacy protection, which is justified for a healthcare company. Overall, the security posture is good but could be enhanced by adding security headers and transparency around incident response. The overall risk assessment is low, with no signs of malicious activity or suspicious content. Strategic recommendations include implementing security headers, publishing security policies, and considering a vulnerability disclosure program to enhance trust and compliance. The website demonstrates a mature digital presence aligned with corporate standards and regulatory requirements.

T

Taiho Ventures, LLC

taihoventures.com

0

Taiho Ventures, LLC is a small investment firm focused on global biotech ventures aligned with the corporate growth strategy of Taiho Pharmaceutical Co., Ltd. The website presents a professional corporate image with clear business focus on biotech investment. The technical infrastructure is basic but functional, using standard HTML, CSS, and JavaScript with cookie consent managed by OneTrust. There is no evidence of advanced CMS or analytics platforms. Security posture is moderate with cookie consent implemented but lacking visible security headers or incident response information. No contact emails or phone numbers are provided on the site, which limits direct communication channels. Overall, the website is trustworthy and consistent with the business claims, but could improve in security transparency and contact accessibility.

B

Bioqube Ventures

bioqubeventures.com

0

Bioqube Ventures is a specialist life sciences venture capital firm operating primarily in Europe and the US, focusing on investing in innovative therapeutic assets and technologies. Their business model includes both classical investment rounds and venture creation projects, leveraging in-house expertise to translate scientific innovation into commercial ventures. The website presents a professional image with clear messaging targeting investors and biotech entrepreneurs. Technically, the site is built on WordPress using modern frameworks and plugins, with good SEO and mobile optimization. Security posture is solid with HTTPS and no visible vulnerabilities, though some security headers and privacy mechanisms could be improved. The absence of WHOIS data is a notable concern, reducing trust in domain legitimacy despite the professional web presence. Overall, the site is credible but would benefit from enhanced transparency and compliance features.

I

InduPro, Inc.

induprotx.com

0

InduPro, Inc. is a biotechnology company specializing in proximity-based therapeutics, focusing on manipulating protein interactions on the cell surface to develop novel treatments for diseases. Their proprietary platforms and scientific expertise position them as an innovative player in the healthcare and biotech sectors. The website presents a professional image with detailed team information, scientific content, and clear contact details, targeting pharmaceutical partners, academic researchers, and investors. Technically, the website is built on WordPress with modern plugins and libraries such as Yoast SEO, FullPage.js, and D3.js, indicating a mature digital infrastructure. The site is mobile optimized and uses HTTPS, but lacks some advanced security headers and formal privacy or cookie policies, which are areas for improvement. From a security perspective, the site shows good baseline practices with HTTPS and no visible vulnerabilities or exposed sensitive data. However, the absence of security policies, incident response information, and vulnerability disclosure mechanisms suggests room to enhance security maturity and compliance. The missing WHOIS data introduces some uncertainty about domain legitimacy, though the professional site content mitigates this concern. Overall, InduPro's website is a credible and professional digital presence for a biotech company, with moderate technical and security posture. Strategic improvements in privacy compliance, security policies, and domain registration transparency would strengthen trust and reduce risk.

K

KuLepszemu Psychoterapia

kulepszemu.pl

0

KuLepszemu Psychoterapia is a specialized mental health clinic based in Warsaw, Poland, offering professional psychotherapy services both in-person and online. The clinic emphasizes qualified, accredited psychotherapists and provides a broad range of treatments including depression, anxiety, PTSD, and relationship therapy. Their market position is that of a trusted local provider with a modern digital presence including online booking and psychological testing tools. Technically, the website is built on WordPress with Elementor, integrates multiple analytics and marketing tools, and is optimized for mobile users. Security posture is good with HTTPS and cookie consent mechanisms, though explicit security headers and privacy policies could be improved. Overall, the site is professional, trustworthy, and well-aligned with its healthcare service mission.

U

UCB, Inc.

ucb-usa.com

0

UCB, Inc. is a global biopharmaceutical company focused on improving the lives of people living with severe diseases through innovative medicines and patient-centered solutions. The website presents a professional and well-structured digital presence targeting patients, healthcare professionals, and investors in the United States. The company emphasizes collaboration, innovation, and equitable access to healthcare. Technically, the site is built on Drupal CMS and integrates modern analytics and consent management tools, reflecting a mature digital infrastructure. Security posture is solid with HTTPS and consent mechanisms, though explicit security headers and published security policies are absent. The lack of WHOIS data for the domain is a notable anomaly, suggesting possible privacy protection or registration issues, but the overall trust signals and external domain relationships support legitimacy. Strategic recommendations include enhancing security transparency and verifying domain registration details.

U

UCB Pharma Ltd.

ucbpharma.co.uk

0

UCB Pharma Ltd. is a global biopharmaceutical company with a strong presence in the UK, focusing on neurological, immunological, and rare disease treatments. The website reflects a professional and patient-centric approach, highlighting research centers, clinical trials, and corporate information. The digital infrastructure is built on Drupal CMS with modern analytics and cookie consent tools, ensuring compliance with privacy regulations. Security posture is robust with HTTPS and security headers in place, though explicit security policies and incident response contacts are not published. Overall, the site is trustworthy and well-maintained, supporting UCB's market position as a leading healthcare provider.

U

UCB Farchim S.A.

ucbsuisse.ch

0

UCB Suisse is a major pharmaceutical production site of the Belgian biopharmaceutical group UCB, specializing in medicines for allergies, epilepsy, and autoimmune diseases. The website targets patients, healthcare professionals, and the general public in Switzerland, providing corporate information, news, and patient testimonials. The technical infrastructure is based on Drupal CMS with modern analytics and cookie consent tools, ensuring GDPR compliance and a good user experience. Security posture is strong with HTTPS, security headers, and no visible vulnerabilities, though no dedicated security policy or incident response information is published. Overall, the website is professional, trustworthy, and compliant with privacy regulations.

U

UCB de México S.A. de C.V.

ucb.com.mx

0

UCB de México is a well-established biopharmaceutical company operating for 25 years in Mexico as part of the global UCB group. The company focuses on delivering innovative treatments in immunology and neurology, emphasizing patient care, sustainability, and gender equity. The website is professionally designed using Drupal CMS, with good mobile optimization and accessibility. Privacy and cookie policies are comprehensive and GDPR compliant, with active consent mechanisms. Security posture is strong with HTTPS, security headers, and no visible vulnerabilities, though explicit security policies and incident response contacts are not publicly provided. Overall, the site reflects a credible and trustworthy healthcare business with moderate to good digital maturity.

ユ

ユーシービージャパン株式会社

ucbjapan.com

0

UCB Japan Co. Ltd. operates as a pharmaceutical company specializing in neurology, bone, immunology, inflammation, and rare diseases. The website serves multiple audiences including patients, healthcare professionals, and the general public by providing educational resources, corporate information, and sustainability initiatives. It is a localized subsidiary of the global UCB group, maintaining consistent branding and professional content quality. Technically, the website is built on Drupal CMS and incorporates modern web technologies such as JavaScript, YouTube iframe API, OneTrust for cookie consent, and Google Tag Manager for analytics. The site is mobile-optimized, accessible, and demonstrates good SEO practices. Performance is moderate with no critical technical issues detected. From a security perspective, the site enforces HTTPS, implements key security headers, and uses a cookie consent mechanism compliant with GDPR. No exposed sensitive data or vulnerable libraries were found. However, explicit security policies and incident response contacts are not published, representing an area for improvement. Overall, the website is trustworthy, professionally maintained, and compliant with privacy regulations. The WHOIS data confirms the legitimacy of the domain and its alignment with the business identity. Strategic recommendations include publishing security policies, adding vulnerability disclosure mechanisms, and enhancing transparency on data protection officer contacts.

优

优时比贸易（上海）有限公司

ucbchina.com

0

UCB China operates as the Chinese branch of the global biopharmaceutical company UCB S.A., focusing on innovative biologic treatments for rare diseases such as generalized myasthenia gravis. The website serves patients, healthcare professionals, and job seekers by providing detailed product information, corporate news, and recruitment opportunities. The company positions itself as a leader in precision medicine for rare neuromuscular diseases in China, leveraging global innovation and local expertise. Technically, the website is built on Drupal CMS with modern JavaScript usage and integrates Siteimprove Analytics for performance and user behavior tracking. The site is mobile-optimized, accessible, and SEO-friendly, reflecting a mature digital infrastructure. However, some security headers are not explicitly present, and no public security or incident response policies are published. From a security perspective, the site enforces HTTPS and cookie consent mechanisms, ensuring basic user privacy and data protection compliance. No critical vulnerabilities or suspicious content were detected. The WHOIS data aligns well with the business claims, indicating a legitimate and consistent domain registration. Overall, the website demonstrates a solid security posture with room for improvement in transparency and advanced security controls. The risk assessment is low, with no signs of malicious activity or content safety concerns. Strategic recommendations include enhancing security headers, publishing a vulnerability disclosure policy, and improving privacy policy comprehensiveness to align with GDPR and other regulations.

U

UCB Canada Inc.

ucb-canada.ca

0

UCB Canada Inc. is a well-established pharmaceutical company focused on delivering life-changing medicines primarily in immunology and neurology. The company targets patients, healthcare professionals, and job seekers within Canada, leveraging a strong global parent company presence. The website reflects a mature digital presence with comprehensive patient support programs, healthcare professional resources, and career opportunities. Technically, the site is built on Drupal CMS with modern tracking and consent management tools, ensuring good performance, accessibility, and SEO. Security posture is strong with HTTPS and cookie consent mechanisms, though explicit security headers could be enhanced. Privacy compliance is well addressed with clear policies and GDPR adherence. Overall, the domain registration data aligns well with the business claims, supporting legitimacy and trustworthiness.

U

UCBCares

ucbcares.co.uk

0

UCBCares is a UK-based healthcare information platform focused on providing support and resources related to psoriasis and skin conditions. The website targets healthcare professionals and patients, offering educational content and patient support services. The domain has been active since 2017, indicating a stable presence in its niche market. Technically, the site uses modern frameworks such as Angular and integrates common web technologies including Font Awesome and Google Tag Manager. However, the site lacks visible privacy and cookie policies, which impacts its privacy compliance score. Security posture is moderate, with no detected security headers or explicit incident response information, suggesting room for improvement in security best practices. Overall, the website is professional and functional but would benefit from enhanced transparency and security measures to improve trust and compliance.

T

The Grace Communication Group

gracegroup.us

0

The Grace Communication Group is a specialized biotech communication consultancy based in Sausalito, California. They focus on partnering with biotech companies to develop authentic engagement strategies targeting partners, investors, employees, and patients. Their services include corporate communications, investor relations, employee communications, media relations, and storytelling. The company positions itself as a trusted partner with an expert team tailored to client needs. Technically, the website is built on the Squarespace platform, leveraging modern web technologies such as Typekit fonts and Swiper.js for interactive sliders. The site is mobile optimized and presents a professional design with clear navigation. Performance is moderate, typical of CMS-based sites. From a security perspective, the site enforces HTTPS and shows no immediate vulnerabilities or exposed sensitive data. However, it lacks important security headers and does not provide privacy or cookie policies, which are critical for compliance and user trust. The absence of WHOIS data reduces domain trustworthiness somewhat, though the professional site content supports legitimacy. Overall, the site is well-constructed for its business purpose but should improve privacy compliance and security best practices to enhance trust and regulatory adherence.

S

SV Health Investors

svhealthinvestors.com

0

SV Health Investors is a specialist healthcare fund manager focused on investing in therapeutics, healthcare growth, and medtech sectors. The company positions itself as a transformative investor supporting innovative healthcare breakthroughs. The website reflects a professional and consistent brand image targeting healthcare entrepreneurs, investors, and industry leaders. The business model centers on fund management with multiple investment strategies and dedicated investor portals, indicating a mature market presence since its founding in 2016. Technically, the website employs modern web technologies including custom fonts, video backgrounds, and JavaScript modules. Hosting appears to be on DigitalOcean with integration of Google Analytics and Tag Manager for user tracking. The site is mobile optimized with good SEO practices, though accessibility features are basic. Performance is moderate with room for improvement. Security posture is solid with HTTPS enabled and domain registration protected by client prohibitions, but lacks advanced security headers and DNSSEC. No privacy or cookie policies were found, indicating compliance gaps with GDPR and related regulations. No incident response or vulnerability disclosure information is provided, which could be a risk for security transparency. Overall, the website is professional and trustworthy but would benefit from enhanced privacy compliance, security headers, and explicit contact information to improve user trust and regulatory adherence.

Biogen Switzerland AG operates as a leading biotechnology company focused on pioneering scientific research and innovation in complex and severe diseases, particularly in neurology, neuropsychiatry, immunology, and rare diseases. The website reflects a strong market position with a comprehensive product portfolio and a clear commitment to improving health outcomes. The digital infrastructure is built on Adobe Experience Manager, leveraging modern web technologies including Cookiebot for privacy compliance and Google Analytics for user insights. The site is well-optimized for mobile and accessibility, with consistent branding and professional content presentation. Security posture is solid with HTTPS enforcement and secure cookie practices, though explicit security policies and incident response contacts are not publicly disclosed. Overall, the website demonstrates a mature digital presence aligned with corporate standards and regulatory compliance.

Biogen Sweden AB operates a professional and comprehensive website focused on biotechnology and healthcare, specifically targeting neurological and rare diseases. The company is positioned as a leading global biotechnology firm with a strong presence in Sweden, offering innovative treatments and scientific advancements. The website is well-structured, professionally designed, and provides detailed information about the company's mission, disease areas, career opportunities, and corporate responsibility. Technically, the site leverages Adobe Experience Manager CMS, modern JavaScript libraries, and integrates cookie consent and analytics tools to ensure compliance and user experience. Security posture is solid with HTTPS enforcement and cookie consent mechanisms, though some security headers and explicit security policies are absent. WHOIS data for the domain www.biogen.se is unavailable, likely due to the domain being a subdomain or managed under a parent domain, but the website content and branding strongly support legitimacy. Overall, the site demonstrates a mature digital presence with good privacy compliance and user trust indicators.

Biogen Slovenia is a regional branch of Biogen, a leading global biotechnology company specializing in innovative therapies for complex neurological, neuropsychiatric, immunological, and rare diseases. The website reflects a professional corporate presence with clear branding, comprehensive content about their mission, treatment areas, and corporate responsibility. Technically, the site is built on Adobe Experience Manager, hosted on AWS infrastructure, and employs modern web technologies including jQuery and Cookiebot for privacy compliance. Security posture is strong with HTTPS, secure cookies, and IP anonymization in analytics, though explicit security policies and incident response information are not published. Overall, the site is well-structured, GDPR compliant, and trustworthy, supporting Biogen's market position as a reputable pharmaceutical entity.

Biogen Portugal operates as a leading biotechnology company focused on innovative therapeutic solutions in neurology, neuropsychiatry, specialized immunology, and rare diseases. The website reflects a mature enterprise with a strong market position and a clear mission to improve global health through science. The digital infrastructure is built on Adobe Experience Manager with modern analytics and consent management tools, indicating a well-maintained and compliant online presence. Security posture is solid with HTTPS and cookie security best practices, though explicit security policies and incident response contacts are absent. Overall, the site is professional, trustworthy, and compliant with GDPR, supporting Biogen's reputation as a global healthcare leader.

Biogen Norway AS operates as a leading global biotechnology company specializing in neurology, neuropsychiatry, specialized immunology, and rare diseases. The company focuses on research, development, and innovation to improve patient lives and contribute to a healthier, sustainable world. The website targets healthcare professionals, patients, and stakeholders primarily in Norway, providing comprehensive information about therapies, corporate responsibility, and career opportunities. Technically, the website is built on Adobe Experience Manager CMS, leveraging modern JavaScript libraries such as jQuery and Adobe Helix RUM for performance monitoring. It employs Google Analytics and Google Tag Manager for analytics and tracking, alongside Cookiebot for cookie consent management. The site is mobile-optimized with good SEO and accessibility features, though some accessibility improvements are recommended. From a security perspective, the site enforces HTTPS and uses secure cookies with httpOnly flags. It implements a detailed cookie consent mechanism compliant with GDPR. However, it lacks explicit security headers and published security policies or incident response contacts, which are recommended for enhanced trust and compliance. Overall, the website presents a professional, trustworthy digital presence with strong privacy compliance and good technical implementation. The absence of WHOIS data is a limitation but does not detract significantly from the site's legitimacy given the quality of content and security posture.

Biogen Netherlands B.V. operates as a leading global biotechnology company specializing in the development and commercialization of innovative medicines for complex neurological and rare diseases. The website reflects a mature enterprise with a clear focus on scientific innovation and patient impact, targeting healthcare professionals and patients in the Netherlands. The company is part of the larger Biogen Inc. group, founded in 1978, with a strong market position in neurology and related therapeutic areas. The website content is professionally presented, with comprehensive information about disease areas, products, corporate responsibility, and career opportunities. Technically, the website is built on Adobe Experience Manager, leveraging modern web technologies including Cookiebot for consent management, Google Analytics for traffic analysis, and Adobe Helix RUM for performance monitoring. The site is mobile-optimized and demonstrates good SEO and accessibility practices, though some accessibility features could be enhanced. Hosting appears to be on AWS infrastructure, indicated by load balancer cookies. Security posture is solid with HTTPS enforced, HttpOnly cookies, and a cookie consent mechanism. However, explicit security policies and incident response contacts are not published, representing an area for improvement. No vulnerabilities or suspicious content were detected. Privacy compliance is strong, with GDPR-aligned cookie management and privacy policy. Overall, the website is trustworthy, professional, and well-aligned with the company's business objectives. Strategic recommendations include publishing formal security and incident response policies, enhancing accessibility, and maintaining vigilance on third-party scripts and tracking technologies.

Biogen Lithuania UAB is a subsidiary of the global biotechnology leader Biogen Inc., specializing in innovative treatments for neurological, neuropsychiatric, immunological, and rare diseases. The website presents a professional and consistent brand image, targeting healthcare professionals and patients in Lithuania. The company emphasizes scientific innovation and social responsibility in its mission. Technically, the site is built on Adobe Experience Manager CMS, uses modern JavaScript libraries like jQuery, and integrates Google Analytics and Cookiebot for analytics and privacy compliance. Security posture is solid with HTTPS and cookie security measures, though explicit security headers and incident response information are absent. The WHOIS data is unavailable, limiting domain trust verification, but the website's content and external references support legitimacy. Overall, the site is well-structured, GDPR compliant, and provides a good user experience.

Biogen Latvia SIA operates as a regional branch of the global biotechnology leader Biogen Inc., focusing on innovative therapies for neurological and rare diseases. The website reflects a professional corporate presence with clear branding, comprehensive content about their business focus, and a user-friendly interface optimized for mobile devices. The technical infrastructure leverages Adobe Experience Manager CMS, modern JavaScript libraries, and robust cookie consent management via Cookiebot, ensuring compliance with GDPR and enhancing user privacy. Security posture is strong with HTTPS enforced and secure cookie practices, though there is room for improvement in publishing explicit security policies and headers. Overall, the site demonstrates a mature digital presence aligned with industry standards and regulatory requirements.

Biogen Italia S.r.l. is a large, well-established biotechnology company operating in Italy as a subsidiary of the global Biogen Inc. The company specializes in innovative therapies for neurological, immunological, and rare diseases, with a strong focus on multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease. The website reflects a professional corporate presence with clear branding, comprehensive content, and a user-friendly design targeting healthcare professionals and patients in Italy. Technically, the site is built on Adobe Experience Manager, uses modern analytics and consent management tools, and is hosted likely on AWS infrastructure. Security posture is strong with HTTPS, HttpOnly cookies, and GDPR-compliant cookie consent mechanisms, although no explicit security policy or incident response contacts are published. Overall, the site is trustworthy, compliant, and well-maintained, supporting Biogen's market position as a leader in biotechnology.

Biogen Hungary KFT operates as a local branch of the global biotechnology leader Biogen, focusing on developing therapies in neurology, neuropsychiatry, special immunology, and rare diseases. The website reflects a professional corporate presence with clear branding, comprehensive content about their business focus, and a strong emphasis on scientific innovation and patient care. The company targets healthcare professionals, patients, and stakeholders interested in advanced biotechnological solutions. Technically, the site is built on Adobe Experience Manager, uses modern JavaScript libraries like jQuery, and integrates Cookiebot for GDPR-compliant cookie management. Google Analytics and Google Tag Manager are employed for analytics and marketing purposes, with appropriate consent mechanisms in place. Security posture is strong with HTTPS enforced, security headers present, and no visible vulnerabilities or exposed sensitive data. However, explicit security policies and incident response information are not published, which could be improved. Overall, the site is well-structured, mobile-optimized, and trustworthy, supporting Biogen's market position as a leading biotechnology company.

Biogen Deutschland operates as a leading biotechnology company specializing in the research, development, and provision of innovative pharmaceutical therapies targeting complex and severe diseases, particularly in neurology and rare disorders. The website reflects a mature enterprise-level digital presence with comprehensive content tailored to patients, healthcare professionals, and partners. The company maintains a strong market position with a clear focus on innovation and patient care. Technically, the site leverages Adobe Experience Manager CMS, integrates modern analytics and consent management tools, and is hosted on AWS infrastructure, indicating a robust and scalable platform. Security posture is solid with HTTPS enforcement and cookie consent mechanisms, though there is room for improvement in explicit security policy disclosures and security headers. Overall, the site demonstrates high professionalism, compliance with GDPR, and trustworthy branding.

Biogen France is a large, internationally recognized biotechnology company specializing in innovative therapies for neurological and rare diseases. The website reflects a mature digital presence with comprehensive content about their therapeutic areas, corporate responsibility, and digital health initiatives. The technical infrastructure is built on Adobe Experience Manager with modern JavaScript libraries and analytics tools, ensuring a responsive and user-friendly experience. Security posture is strong with HTTPS, secure cookies, and a robust cookie consent mechanism, although some security headers and explicit security policies are absent. Privacy compliance is well addressed with GDPR-aligned policies and cookie management. Overall, the site demonstrates high professionalism and trustworthiness, supporting Biogen's market position as a leader in healthcare innovation.

Biogen is a leading global biotechnology company specializing in innovative treatments for complex and devastating diseases, particularly in neurology, neuropsychiatry, specialized immunology, and rare diseases. The Finnish website reflects the company's commitment to science-driven healthcare solutions and social responsibility. The site is professionally designed with clear navigation and consistent branding, targeting a general audience including patients, healthcare professionals, and potential employees. Technically, the website leverages Adobe Experience Manager as its CMS, integrates modern analytics and consent management tools such as Google Analytics and Cookiebot, and employs HTTPS with secure cookie practices. Security posture is solid with room for improvement in security headers and explicit security policies. Privacy compliance is strong, with comprehensive privacy and cookie policies and GDPR-aligned consent mechanisms. No critical vulnerabilities or suspicious content were detected, and the WHOIS data aligns well with the company's legitimacy and business claims.

Biogen Estonia OÜ operates as a local branch of the global biotechnology leader Biogen Inc., focusing on innovative treatments for complex neurological, neuropsychiatric, immunological, and rare diseases. The website is professionally designed, localized in Estonian, and provides comprehensive information about the company's mission, disease areas, and career opportunities. The digital infrastructure is built on Adobe Experience Manager, leveraging modern technologies such as jQuery, Google Tag Manager, and Cookiebot for consent management. Security posture is strong with HTTPS enforced and privacy-conscious analytics configuration. However, explicit security policies and incident response contacts are not published, representing an area for improvement. Overall, the website demonstrates a mature digital presence aligned with corporate standards and regulatory compliance.

Biogen (Denmark) A/S is a leading global biotechnology company focused on innovative research and development of treatments for serious and complex diseases, including neurological, neuropsychiatric, immunological, and rare diseases. The website reflects a professional corporate presence targeting healthcare professionals, patients, and potential employees. The company positions itself as a pioneer in healthcare innovation with a commitment to improving patient lives and societal health. Technically, the website is built on Adobe Experience Manager CMS, utilizing modern JavaScript libraries such as jQuery and Adobe Helix RUM for performance monitoring. It employs Google Analytics and Google Tag Manager for user analytics and tracking, complemented by a comprehensive cookie consent mechanism compliant with GDPR requirements. Security posture is strong with HTTPS enforced and use of secure cookies, though the absence of explicit security policies and incident response information is noted. The lack of WHOIS data for the domain slightly reduces trustworthiness but does not detract significantly from the overall legitimacy given the professional content and branding. Strategic recommendations include enhancing security headers, publishing security and incident response policies, and improving accessibility compliance.

Biogen.hr is the Croatian localized website of Biogen, a leading global biotechnology company specializing in innovative therapies for complex neurological and rare diseases. The website presents a professional and well-structured digital presence, leveraging Adobe Experience Manager CMS and hosted on AWS infrastructure. It features comprehensive cookie consent management via Cookiebot and integrates Google Analytics with IP anonymization, demonstrating a commitment to privacy compliance. While the site lacks explicit published security or incident response policies, it employs secure HTTPS protocols and best practices such as HttpOnly cookies. The content is targeted at a general audience in Croatia, focusing on healthcare professionals, patients, and stakeholders interested in Biogen's therapeutic areas and corporate responsibility. Overall, the website reflects a mature, trustworthy, and professional digital asset aligned with Biogen's global brand.

Biogen Belgium SA operates as a regional branch of the global biotechnology leader Biogen Inc., focusing on innovative therapies in neurology, neuropsychiatry, immunology, and rare diseases. The website targets healthcare professionals and patients in Belgium and Luxembourg, providing corporate information, therapeutic areas, and career opportunities. The digital infrastructure is built on Adobe Experience Manager with modern JavaScript libraries and integrates Google Analytics and Cookiebot for privacy compliance. Security posture is strong with HTTPS and secure cookies, though explicit security policies and incident response details are absent. The WHOIS data is restricted, common for .be domains, but the website's professional presentation and consistent branding support legitimacy. Overall, the site demonstrates a mature digital presence aligned with corporate standards.

Biogen is a globally recognized biotechnology company with a strong presence in Austria, focusing on pioneering scientific research and innovation in complex and severe diseases such as neurology, neuropsychiatry, immunology, and rare diseases. The website reflects a professional corporate identity with consistent branding and clear communication of their mission to improve health outcomes through science. Technically, the site is built on Adobe Experience Manager, uses modern JavaScript libraries like jQuery, and integrates Google Analytics and Cookiebot for analytics and privacy compliance. Security posture is solid with HTTPS enforced and HttpOnly cookies, though some security headers are not explicitly detected. Privacy compliance is well addressed with comprehensive cookie and privacy policies and a consent mechanism. The absence of WHOIS data is likely due to privacy protection, which is justified for this enterprise-level healthcare company. Overall, the website is trustworthy, well-maintained, and compliant with relevant regulations.

C

Chiesi Poland Sp. z o.o.

oddychajmy.pl

0

Oddychajmy.pl is a professionally developed healthcare portal operated by Chiesi Poland Sp. z o.o., focusing on providing comprehensive information, education, and support for patients suffering from Chronic Obstructive Pulmonary Disease (POChP) and their families. The website offers a variety of resources including expert articles, video tutorials, diagnostic guidance, and risk assessment tools, positioning itself as a niche but trusted source in the Polish healthcare information market. The content is well-structured, medically oriented, and targeted specifically at patients and caregivers, enhancing its relevance and utility. From a technical perspective, the website is built on the WordPress CMS platform, utilizing modern web technologies such as Bootstrap for responsive design, jQuery for interactivity, and integrates Google Tag Manager and Google Analytics for tracking and marketing purposes. The site demonstrates good mobile optimization, accessibility features, and SEO practices, though hosting provider details are not explicitly identified. Performance is moderate, with no critical technical issues detected. Security-wise, the site enforces HTTPS and implements a GDPR-compliant cookie consent mechanism with granular user controls, reflecting a strong privacy posture. However, there is a lack of explicit security headers and no publicly available security or incident response policies, which could be areas for improvement. No vulnerabilities or suspicious content were detected, and the WHOIS data aligns well with the business information, indicating legitimacy and trustworthiness. Overall, Oddychajmy.pl presents a low-risk profile with a solid foundation in content quality, privacy compliance, and business credibility. Strategic enhancements in security policy transparency and technical security headers would further strengthen its security posture and user trust.

C

Chiesi Poland Sp. z o.o.

totylkoastma.pl

0

The website 'To Tylko Astma' is a professionally developed healthcare education platform focused on asthma awareness and management in Poland. Sponsored by Chiesi Poland Sp. z o.o., a pharmaceutical company, it provides comprehensive educational content, multimedia resources, and reports targeting patients and caregivers across various age groups. The site leverages modern web technologies including WordPress, Bootstrap, and integrates analytics and user feedback tools such as Google Analytics, Hotjar, and Qualtrics to enhance user engagement and data-driven improvements. Security posture is strong with HTTPS enforced and no visible vulnerabilities, although security headers could be improved. Privacy and cookie policies are comprehensive and GDPR compliant, with clear contact information and transparent business details enhancing trustworthiness.

E

Everyday Health

everydayhealth.com

0

Everyday Health is a well-established digital health media company founded in 2002, providing trusted, medically reviewed health information, expert advice, and wellness resources to a broad audience. The website offers extensive content on health conditions, nutrition, fitness, product reviews, and tools such as symptom checkers and vaccine planners. It targets general consumers seeking reliable health information and wellness guidance. Technically, the site uses modern web technologies including React and Sitefinity CMS, with integrations for advertising and analytics through reputable providers like Google Tag Manager and Rubicon Project. The site is mobile-optimized and demonstrates good SEO and accessibility practices. Security-wise, the site enforces HTTPS, uses reCAPTCHA for bot protection, and implements cookie consent mechanisms, but lacks explicit security headers and a published security.txt file. The WHOIS data for the domain is unavailable, which slightly reduces domain registration transparency, but the site's content quality, editorial policies, and social media presence strongly support its legitimacy. Overall, the site is professional, trustworthy, and well-maintained, with minor areas for security and transparency improvement.

S

Sprida Reklambyrå

sprida.se

0

Sprida Reklambyrå is a Stockholm-based advertising agency specializing in healthcare and pharmaceutical marketing communications, serving primarily the Nordic market. Established since 1997, the company offers services including strategic communication, design, web development, and copywriting. The website reflects a professional small business with consistent branding and clear contact information. Technically, the site uses modern web standards and Google Tag Manager for analytics, hosted by LoopiaGroup2. Security posture is adequate with HTTPS enabled but lacks advanced security headers and DNSSEC. Privacy compliance is weak due to absence of privacy and cookie policies. Overall, the site is trustworthy and well-maintained but could improve compliance and security practices.

M

MedAdvisor International Pty Limited

medsinfo.com.au

0

medsinfo.com.au is a specialized healthcare information website providing up-to-date Consumer Medicine Information (CMI) and Product Information (PI) for medicines approved in Australia. Sponsored and funded by MedAdvisor International Pty Limited, the site targets both consumers and health professionals, supporting the National Strategy for the Quality Use of Medicines. The business model focuses on free access to authoritative medicine information without advertising, enhancing trust and user experience. Technically, the site is built on Angular framework with modern web technologies and uses Cloudflare DNS services. Google Tag Manager is employed for analytics, although no cookie consent mechanism is present. Security posture is moderate with HTTPS enforced but lacking explicit security headers and published security policies. WHOIS data indicates a consistent and legitimate domain registration with no privacy protection, aligning with the business purpose. Overall, the website is professional, trustworthy, and content-rich, but could improve privacy compliance and security best practices.

U

UCB Pharma Sp. z o.o.

ucb.pl

0

UCB Pharma Sp. z o.o. is a pharmaceutical company operating in Poland, focused on providing prescription medicines and patient support for serious diseases. The company is part of the global UCB group and targets patients, healthcare professionals, and pharmacies. The website is professionally designed using Drupal CMS, with good mobile optimization and accessibility features. It employs modern analytics and cookie consent tools to ensure compliance and user tracking moderation. Security posture is strong with HTTPS, security headers, and no visible vulnerabilities, although explicit security policies and incident response information are not published. Overall, the website reflects a trustworthy and credible business presence in the healthcare sector.

Teva Poland operates as a pharmaceutical company specializing in generic and specialty medicines, positioning itself as a global leader in generic drug manufacturing. The website is professionally designed, targeting patients, healthcare professionals, and pharmacies in Poland. It offers comprehensive information about products, corporate responsibility, and patient support initiatives. The digital infrastructure leverages modern JavaScript libraries and analytics tools, ensuring good performance and user experience across devices. Security posture is solid with HTTPS and cookie consent mechanisms, though some security headers and explicit policies could be enhanced. The absence of WHOIS data is due to registry privacy policies, which is common and justified for such enterprises. Overall, the website reflects a mature, trustworthy business presence with moderate tracking and compliance adherence.

S

Servier

servier.pl

0

Servier Polska operates as a pharmaceutical company in Poland, providing healthcare products and services primarily targeting healthcare professionals and patients. The website reflects a corporate presence with basic content and design elements, including the use of Font Awesome Pro icons. The domain is well-established since 1998 and secured with DNSSEC, indicating a legitimate and trustworthy entity. However, the website lacks visible privacy, cookie, and terms of service policies, as well as explicit contact information, which limits transparency and user trust. Technically, the site uses modern iconography but lacks evidence of advanced frameworks or analytics tools. Security posture is moderate with HTTPS and DNSSEC enabled but missing key security headers and policies. Overall, the site is safe for general audiences with no adult or explicit content detected.

S

Sanofi Pasteur

sanofipasteur.pl

0

The domain sanofipasteur.pl currently hosts a parked page with no active business content, serving as a placeholder rather than an operational website. Sanofi Pasteur is a globally recognized healthcare company specializing in vaccines, but this domain does not reflect active digital presence or business operations. The technical infrastructure is minimal, relying on an iframe to a parking service and loading consent management scripts without actual consent banners or policies. Security posture is weak due to lack of DNSSEC, security headers, and HTTPS details. The domain's recent registration date is inconsistent with the established brand history, suggesting this is a newly acquired or reserved domain rather than an official site. Overall, the website lacks essential compliance, contact, and trust indicators.

R

Roche Polska

roche.pl

0

Roche Polska is a leading healthcare company in Poland, providing innovative solutions in health protection. The website reflects a professional and consistent brand image aligned with Roche's global identity. The target audience includes healthcare professionals and patients within Poland. Technically, the site is built using modern frameworks such as Gatsby and React, offering good mobile optimization and accessibility. However, there is a lack of visible privacy and cookie policies, security headers, and explicit contact information, which are areas for improvement. The security posture is moderate with no detected blocking or WAF interference, but the absence of security best practices lowers the overall security score. Overall, the website is credible and trustworthy but could enhance compliance and security transparency.

N

Novo Nordisk

novonordisk.pl

0

Novo Nordisk Polska is the Polish branch of Novo Nordisk, a leading global healthcare company specializing in innovative therapies for chronic diseases such as diabetes, obesity, haemophilia, and menopause. The website serves Polish patients, healthcare professionals, and job seekers, providing comprehensive information about the company's scientific approach, heritage, and business activities. The company holds a strong market position with over 100 years of history and operates as an enterprise-level pharmaceutical business.